The Supreme Court has taken suo motu cognisance of a significant delay in the Kerala High Court’s handling of a petition aimed at reducing the cost of a crucial breast cancer medication. This decision comes after the woman who filed the plea reportedly passed away prior to the hearing of her case. The matter was addressed by a Bench led by Chief Justice of India Surya Kant.

Details of the Petition

The petition, submitted in June 2022, sought a decrease in the price of a life-saving drug effective for breast cancer treatment. According to the petitioner’s lawyer, the case has been pending in the Kerala High Court for almost four years, having been listed for hearing a total of fifty-seven times without reaching a resolution. Tragically, the petitioner’s death has underscored the urgency of the matter, with her legal representative commenting that the situation is now “too late” for her.

Despite the passing of the petitioner, the Kerala High Court opted not to dismiss the case. The court highlighted that the issue at hand is of broader significance, impacting other patients who are similarly in need of access to costly medication. This stance reflects a commitment to address systemic concerns surrounding healthcare affordability.

Renewed Attention and Action Taken

The situation gained renewed attention following the submission of a letter to the Chief Justice of the Kerala High Court, which requested an expedited hearing. This correspondence was also shared with President Droupadi Murmu and Chief Justice Surya Kant. The urgency of the appeal prompted CJI Surya Kant to take action, resulting in the matter being brought before the Supreme Court for hearing.

Implications for the Healthcare System

The case raises important questions regarding the accessibility and affordability of essential medications in India. With the ongoing discussions surrounding healthcare reforms, this petition highlights the disparities faced by patients reliant on costly treatments. The delayed judicial process has now placed heightened scrutiny on the legal mechanisms concerning drug pricing and patient rights.

As the Supreme Court has issued a notice to the Centre in response to this matter, it may prompt a re-examination of current policies governing drug pricing. The court’s involvement is seen as a potential catalyst for change, addressing not only the individual circumstances of the petitioner but also the larger implications for healthcare access across the nation.

The judicial response emphasises the importance of timely resolutions in legal proceedings that affect health outcomes. This case serves as a reminder of the urgent need to streamline processes to ensure that patients receive the necessary treatments within a reasonable timeframe.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share